Zolmitriptan (a 5-HT1B/1Dreceptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

✍ Scribed by M.L. Boshuisen; J.A. den Boer

• Publisher: Springer
• Year: 2000
• Tongue: English
• Weight: 52 KB
• Volume: 152
• Category: Article
• ISSN: 0033-3158
• DOI: 10.1007/s002130000529